References
1. Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: Global
estimates of diabetes prevalence for 2017 and projections for 2045.
Diabetes Res Clin Pract. 2018;138: 271-281.
2. Papatheodorou K, Banach M, Bekiari E, et al. Complications of
Diabetes 2017. J Diabetes Res. 2018;2018: 3086167.
3. Bakker K, van Houtum WH, Riley PC. 2005: The International Diabetes
Federation focuses on the diabetic foot. Curr Diab Rep. 2005;5(6):
436-440.
4. Armstrong DG, Boulton AJM, Bus SA. Diabetic Foot Ulcers and Their
Recurrence. New Engl J Med. 2017;376(24): 2367-2375.
5. Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of
ischaemia, infection and serious comorbidity in patients with diabetic
foot disease in Europe. Baseline results from the Eurodiale study.
Diabetologia. 2007;50(1): 18-25.
6. Oyibo SO, Jude EB, Tarawneh I, et al. A comparison of two diabetic
foot ulcer classification systems: the Wagner and the University of
Texas wound classification systems. Diabetes Care. 2001;24(1): 84-88.
7. Wagner FW, Jr. The dysvascular foot: a system for diagnosis and
treatment. Foot Ankle. 1981;2(2): 64-122.
8. Pendsey SP. Understanding diabetic foot. Int J Diabetes Dev Ctries.
2010;30(2): 75-79.
9. Jeon BJ, Choi HJ, Kang JS, et al. Comparison of five systems of
classification of diabetic foot ulcers and predictive factors for
amputation. Int Wound J. 2017;14(3): 537-545.
10. Massara M, De Caridi G, Serra R, et al. The role of procalcitonin as
a marker of diabetic foot ulcer infection. International Wound Journal.
2017;14(1): 31-34.
11. Coverdale JPC, Katundu KGH, Sobczak AIS, et al. Ischemia-modified
albumin: Crosstalk between fatty acid and cobalt binding. Prostaglandins
Leukot Essent Fatty Acids. 2018;135: 147-157.
12. Menon B, Ramalingam K, Krishna V. Study of Ischemia Modified Albumin
as a Biomarker in Acute Ischaemic Stroke. Ann Neurosci. 2018;25(4):
187-190.
13. Piwowar A, Knapik-Kordecka M, Warwas M. Ischemia-modified albumin
level in type 2 diabetes mellitus - Preliminary report. Dis Markers.
2008;24(6): 311-317.
14. Ghosh K, Muddeshwar MG, Ghosh K. Ischemia Modified Albumin Test to
Detect Early Diabetic Complications. Am J Med Sci. 2017;354(5): 467-470.
15. Muhtaroglu S, Barlak Keti D, Unluhizarci K. Investigation of
ischemia-modified albumin levels and some atherosclerosis-related serum
parameters in patients with diabetic foot. Turk J Med Sci. 2016;46(1):
126-132.
16. Wagner FW, Jr. The diabetic foot. Orthopedics. 1987;10(1): 163-172.
17. Pendsey S. Classification and staging. In: Diabetic Foot. A Clinical
Atlas. London, England: CRC Press; 2013.
18. Lavery LA, Armstrong DG, Peters EJ, et al. Probe-to-bone test for
diagnosing diabetic foot osteomyelitis: reliable or relic? Diabetes
Care. 2007;30(2): 270-274.
19. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin
binding and its potential as a marker for myocardial ischemia - A
preliminary report. J Emerg Med. 2000;19(4): 311-315.
20. Sullivan GM, Feinn R. Using Effect Size-or Why the P Value Is Not
Enough. J Grad Med Educ. 2012;4(3): 279-282.
21. Guo Z, Yue C, Qian Q, et al. Factors associated with lower-extremity
amputation in patients with diabetic foot ulcers in a Chinese tertiary
care hospital. Int Wound J. 2019;16(6): 1304-1313.
22. Hadavand F, Amouzegar A, Amid H. Pro-Calcitonin, Erythrocyte
Sedimentation Rate and C - reactive Protein in Predicting Diabetic Foot
Ulcer Characteristics; a Cross Sectional Study. Arch Acad Emerg Med.
2019;7(1): 37.
23. Jeandrot A, Richard JL, Combescure C, et al. Serum procalcitonin and
C-reactive protein concentrations to distinguish mildly infected from
non-infected diabetic foot ulcers: a pilot study. Diabetologia.
2008;51(2): 347-352.
24. Ozkan S, Adanas C. Do Hba1c, LDL and HDL Levels Determine The Level
of Amputation? Acta Medica Mediterr. 2019;35(5): 2481-2485.
25. Ukinc K, Eminagaoglu S, Ersoz HO, et al. A novel indicator of
widespread endothelial damage and ischemia in diabetic patients:
ischemia-modified albumin. Endocrine. 2009;36(3): 425-432.
26. Turk A, Nuhoglu I, Mentese A, et al. The Relationship between
Diabetic Retinopathy and Serum Levels of Ischemia-Modified Albumin and
Malondialdehyde. Retina-J Ret Vit Dis. 2011;31(3): 602-608.
27. Gunduz A, Mentese A, Turedi S, et al. Serum ischaemia-modified
albumin increases in critical lower limb ischaemia. Emerg Med J.
2008;25(6): 351-353.
28. Muhtaroglu S, Keti DB, Unluhizarci K. Investigation of
ischemia-modified albumin levels and some atherosclerosis-related serum
parameters in patients with diabetic foot. Turkish Journal of Medical
Sciences. 2016;46(1): 126-132.
29. Raheem GS, Al-Barzinji RM, Al-Dabbagh AA. Association of C-Reactive
protein levels with Wagner grades of diabetic foot ulceration. The Third
International conference of Medical Sciences. Ieaq; 2020:182-188.